Virological and immunological connotations of apoptotic and anti-apoptotic forces in neoplasia

J G Sinkovics1, J C Horvath

  • 1Cancer Institute, St. Joseph's Hospital, 3001 W. Dr. Martin Luther King Jr. Blvd., Tampa, FL 33607-6387, USA. sinkovi.joseph@baycare.org

Insights

Programmed cell death (apoptosis) plays a crucial role in cancer biology, influencing tumor growth and treatment resistance. Understanding apoptosis mechanisms offers potential therapeutic strategies against cancers like leukemia, melanoma, lymphoma, and Hodgkin's disease.

Area of Science:

  • Cell Biology
  • Immunology
  • Oncology

Background:

  • Programmed cell death (apoptosis) is a fundamental biological process with implications in various diseases.
  • Mesenchymal stromal cells can protect chronic lymphocytic leukemia cells from apoptosis.
  • Apoptosis resistance in melanoma cells involves the Fas ligand-Fas receptor system.

Purpose of the Study:

  • To explore the biological contexts and demonstration techniques of programmed cell death (apoptosis).
  • To investigate the role of apoptosis in chronic lymphocytic leukemia, melanoma, lymphoma, and Hodgkin's disease.
  • To identify potential therapeutic interventions that induce apoptosis in tumor cells.

Main Methods:

  • Review of fundamental biological contexts and techniques for demonstrating apoptosis.
  • Observation of mesenchymal stromal cells as feeder layers for chronic lymphocytic leukemia cells.
  • Analysis of the Fas ligand-Fas receptor system in melanoma cells and bi-directional apoptosis induction in lymphomas and chemotherapy-resistant Hodgkin's disease.

Main Results:

  • Mesenchymal stromal cells act as protective 'nurse cells' for chronic lymphocytic leukemia cells.
  • Apoptosis-resistant melanoma cells utilize the FasL-FasR system for autocrine growth.
  • Bi-directional apoptosis induction observed between cytotoxic lymphocytes and tumor cells, and chemotherapy-induced apoptosis in malignant cells.

Conclusions:

  • Apoptosis is a critical factor in cancer progression and treatment response.
  • Targeting apoptosis pathways presents potential therapeutic avenues for various cancers.
  • Understanding the balance of apoptotic and anti-apoptotic forces is key for developing effective cancer therapies.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...